The p53 Arg72Pro and MDM2 -309 polymorphisms and risk of breast cancer in the nurses’ health studies

Author： Cox David   Deer Dwayne   Guo Qun   Tworoger Shelley   Hankinson Susan   Hunter David   Vivo Immaculata  

Publisher： Springer Publishing Company

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.18, Iss.6, 2007-08, pp. : 621-625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer

By                            

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 673-677

Spandidos Publications

Access to resources Recommend Favorite

p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population

By Sreeja Leelakumari   Syamala Vani   Raveendran Praveenkumar   Santhi Sarojam   Madhavan Jayaprakash   Ankathil Ravindran  

Cancer Investigation, Vol. 26, Iss. 1, 2007-12 ,pp. : 41-46

Informa Healthcare

Access to resources Recommend Favorite

p53 codon 72 polymorphism and breast cancer risk: A meta-analysis

By        

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1397-1402

Spandidos Publications

Access to resources Recommend Favorite

Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer

By      

Molecular Medicine Reports, Vol. 6, Iss. 3, 2012-01 ,pp. : 473-476

Spandidos Publications

Access to resources Recommend Favorite

Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wildtype p53 breast cancer cells

By              

International Journal of Oncology, Vol. 43, Iss. 6, 2013-01 ,pp. : 1935-1942

Spandidos Publications

Access to resources Recommend Favorite